205 related articles for article (PubMed ID: 27601336)
1. Near infrared spectroscopy to monitor drug release in-situ during dissolution tests.
Sarraguça MC; Matias R; Figueiredo R; Ribeiro PR; Martins AT; Lopes JA
Int J Pharm; 2016 Nov; 513(1-2):1-7. PubMed ID: 27601336
[TBL] [Abstract][Full Text] [Related]
2. Assessment of mefenamic acid polymorphs in commercial tablets using chemometric coupled to MIR and NIR spectroscopies. Prediction of dissolution performance.
Antonio M; Maggio RM
J Pharm Biomed Anal; 2018 Feb; 149():603-611. PubMed ID: 29202439
[TBL] [Abstract][Full Text] [Related]
3. A process analytical technology approach based on near infrared spectroscopy: tablet hardness, content uniformity, and dissolution test measurements of intact tablets.
Blanco M; Alcalá M; González JM; Torras E
J Pharm Sci; 2006 Oct; 95(10):2137-44. PubMed ID: 16883562
[TBL] [Abstract][Full Text] [Related]
4. Dissolution assessment of allopurinol immediate release tablets by near infrared spectroscopy.
Smetiško J; Miljanić S
J Pharm Biomed Anal; 2017 Oct; 145():322-330. PubMed ID: 28709129
[TBL] [Abstract][Full Text] [Related]
5. Dissolution testing of isoniazid, rifampicin, pyrazinamide and ethambutol tablets using near-infrared spectroscopy (NIRS) and multivariate calibration.
de Oliveira Neves AC; Soares GM; de Morais SC; da Costa FS; Porto DL; de Lima KM
J Pharm Biomed Anal; 2012 Jan; 57():115-9. PubMed ID: 21908131
[TBL] [Abstract][Full Text] [Related]
6. Sustained release dosage forms dissolution behavior prediction: a study of matrix tablets using NIR spectroscopy.
Tabasi SH; Moolchandani V; Fahmy R; Hoag SW
Int J Pharm; 2009 Dec; 382(1-2):1-6. PubMed ID: 19660535
[TBL] [Abstract][Full Text] [Related]
7. Assessment of powder blend uniformity: Comparison of real-time NIR blend monitoring with stratified sampling in combination with HPLC and at-line NIR Chemical Imaging.
Bakri B; Weimer M; Hauck G; Reich G
Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):78-89. PubMed ID: 26455421
[TBL] [Abstract][Full Text] [Related]
8. High-throughput NIR-chemometric methods for chemical and pharmaceutical characterization of sustained release tablets.
Porfire A; Filip C; Tomuta I
J Pharm Biomed Anal; 2017 May; 138():1-13. PubMed ID: 28171787
[TBL] [Abstract][Full Text] [Related]
9. Prediction of Dissolution Profiles From Process Parameters, Formulation, and Spectroscopic Measurements.
Zhao Y; Li W; Shi Z; Drennen JK; Anderson CA
J Pharm Sci; 2019 Jun; 108(6):2119-2127. PubMed ID: 30742835
[TBL] [Abstract][Full Text] [Related]
10. Process analytical technology in continuous manufacturing of a commercial pharmaceutical product.
Vargas JM; Nielsen S; Cárdenas V; Gonzalez A; Aymat EY; Almodovar E; Classe G; Colón Y; Sanchez E; Romañach RJ
Int J Pharm; 2018 Mar; 538(1-2):167-178. PubMed ID: 29355655
[TBL] [Abstract][Full Text] [Related]
11. Multivariate approaches for the development of quality control in-situ fiber optics dissolution methods for fixed-dose combination tablets.
Medendorp J; Colón I; Ryan T
Drug Dev Ind Pharm; 2019 Jun; 45(6):999-1008. PubMed ID: 30905176
[TBL] [Abstract][Full Text] [Related]
12. Prediction of drug dissolution from tablets using near-infrared diffuse reflectance spectroscopy as a nondestructive method.
Donoso M; Ghaly ES
Pharm Dev Technol; 2004 Aug; 9(3):247-63. PubMed ID: 15458231
[TBL] [Abstract][Full Text] [Related]
13. Predicting the dissolution behavior of pharmaceutical tablets with NIR chemical imaging.
Yekpe K; Abatzoglou N; Bataille B; Gosselin R; Sharkawi T; Simard JS; Cournoyer A
Int J Pharm; 2015; 486(1-2):242-51. PubMed ID: 25835268
[TBL] [Abstract][Full Text] [Related]
14. Towards a real time release approach for manufacturing tablets using NIR spectroscopy.
Pestieau A; Krier F; Thoorens G; Dupont A; Chavez PF; Ziemons E; Hubert P; Evrard B
J Pharm Biomed Anal; 2014 Sep; 98():60-7. PubMed ID: 24880992
[TBL] [Abstract][Full Text] [Related]
15. Development and validation of an in-line NIR spectroscopic method for continuous blend potency determination in the feed frame of a tablet press.
De Leersnyder F; Peeters E; Djalabi H; Vanhoorne V; Van Snick B; Hong K; Hammond S; Liu AY; Ziemons E; Vervaet C; De Beer T
J Pharm Biomed Anal; 2018 Mar; 151():274-283. PubMed ID: 29413975
[TBL] [Abstract][Full Text] [Related]
16. Prediction of drug dissolution profiles from tablets using NIR diffuse reflectance spectroscopy: a rapid and nondestructive method.
Freitas MP; Sabadin A; Silva LM; Giannotti FM; do Couto DA; Tonhi E; Medeiros RS; Coco GL; Russo VF; Martins JA
J Pharm Biomed Anal; 2005 Sep; 39(1-2):17-21. PubMed ID: 15935597
[TBL] [Abstract][Full Text] [Related]
17. Near-infrared spectroscopic analysis of the breaking force of extended-release matrix tablets prepared by roller-compaction: influence of plasticizer levels and sintering temperature.
Dave VS; Fahmy RM; Hoag SW
Drug Dev Ind Pharm; 2015 Jun; 41(6):898-905. PubMed ID: 24785574
[TBL] [Abstract][Full Text] [Related]
18. Quality control of multi-component, intact pharmaceutical tablets with three different near-infrared apparatuses.
Cournoyer A; Simard JS; Cartilier L; Abatzoglou N
Pharm Dev Technol; 2008; 13(5):333-43. PubMed ID: 18798121
[TBL] [Abstract][Full Text] [Related]
19. An Application for the Quantitative Analysis of Pharmaceutical Tablets Using a Rapid Switching System Between a Near-Infrared Spectrometer and a Portable Near-Infrared Imaging System Equipped with Fiber Optics.
Murayama K; Ishikawa D; Genkawa T; Ozaki Y
Appl Spectrosc; 2018 Apr; 72(4):551-561. PubMed ID: 29262698
[TBL] [Abstract][Full Text] [Related]
20. Blend uniformity end-point determination using near-infrared spectroscopy and multivariate calibration.
Sulub Y; Konigsberger M; Cheney J
J Pharm Biomed Anal; 2011 Jun; 55(3):429-34. PubMed ID: 21398064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
